Innovation Portfolio
University of Bonn
Excellence university with renowned research in mathematics, physics, economics, and life sciences. Strong focus on sustainability research, artificial intelligence, and matter research clusters.
227
Patents
608
Inventors
27
Spin-offs
Patent Portfolio
Analysis of our organization's intellectual property assets
Patents by Technology Area
Portfolio Highlights
Total Patents
227
Recent Patent Publications (2025 & 2026)
7
Top Inventors
Patent Portfolio
Featured Technologies
Discover our latest patented technologies
CONSTRUCT COMPRISING mRNA-STRAND AND RETINOIC ACID-INDUCIBLE GENE I (RIG-I)-LIGAND(S), PHARMACEUTICAL COMPOSITION AND KIT COMPRISING THE SAME
This patent describes a new type of construct for mRNA-based vaccines and therapeutics, in which one or more special short double-stranded RNA molecules (RIG-I ligands) are directly attached to the mRNA strand using a flexible linker. The RIG-I ligands are designed to activate the body's innate immune response in a predictable manner by stimulating the RIG-I immune receptor, mimicking how viral RNAs are detected during infections. The result is a more controlled and robust immune activation when the mRNA vaccine or therapeutic is administered, improving the efficacy and safety of mRNA-based interventions.
Use of Cellobiofructose and Production Method Thereof
This patent describes the use of cellobiofructose (CBF), a novel trisaccharide, as a dietary fiber and prebiotic in foods, beverages, nutraceuticals, and pharmaceuticals. It details both the health benefits of CBF—such as promoting beneficial gut bacteria and not raising blood sugar—and an improved, efficient biotechnological method for producing high-purity CBF using engineered host microorganisms expressing levansucrase. CBF is highly soluble, can replace sugar as a low-calorie sweetener, and supports the growth of probiotic bacteria.
Means and Methods for Linking Genetic Perturbations or the Expression of a Gene or Rna of Interest with Phenotypes of Cells
This invention describes a method and nucleic acid constructs for linking genetic changes (such as gene editing or expression of specific RNAs) in individual cells to their observable phenotypes. It enables researchers to introduce unique genetic perturbations to each cell, label these changes with DNA/RNA barcodes, and directly map which genetic changes correspond to which cellular behaviors or characteristics, all using advanced in situ sequencing and imaging. The approach works in a wide range of cell types, does not depend on the cell's transcriptional activity, and supports high-throughput, genome-scale experiments.
Success Stories
Featured Spin-off Companies
Companies founded based on our organization's technologies
XOII Foods
XOII Foods is a Munich food producer offering organic, handcrafted vegan and vegetarian products, with a focus on Asian-style tofu and soy foods made from regional ingredients. The company also hosts workshops and community events to share plant-based culinary traditions.
LightningPose
Lightning Pose App is a browser-based GUI for creating, training, and running inference for pose estimation projects in the cloud or locally.
WingGuard
WingGuard is an online shop for sustainable, vegan, and plastic-free household and body-care products, combining curated eco brands with its own lines.
Contact the Technology Transfer Office
The Transfer Center enaCom Technology Transfer team is ready to assist you with licensing inquiries and collaboration opportunities
Get in Touch
Phone
+49 228 73-2210
wolf@verwaltung.uni-bonn.de
Address
Regina-Pacis-Weg 3 53113 Bonn Germany
Office Hours
Monday - Friday: 9:00 AM - 4:00 PM